Tractinostat

N/A

Report date: 2023/05/05 17:09:07
NME

Base Information

Drug NameTractinostat
Drug Alias NameNanatinostatCHR-3996VRx-3996
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsSolid tumoursLymphoproliferative DisordersNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsUnited Kingdom +[5
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChroma Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViracta Therapeutics Inc
Inactive CompaniesChroma Therapeutics Ltd
Active IndicationsLymphoproliferative Disorders
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A